...
首页> 外文期刊>International Journal of Pharmaceutics >Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
【24h】

Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.

机译:使用喷气雾化器和新型的具有大网孔的微泵装置输送的脂质体的物理稳定性和气溶胶特性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aerosol properties of liposomes and their physical stability to aerosolization were evaluated using an air-jet nebulizer (Pari LC Plus) and a customized large aperture vibrating-mesh nebulizer (Aeroneb Pro-8microm). Soya phosphatidylcholine: cholesterol (1:1 mole ratio) multilamellar liposomes (MLVs) entrapping salbutamol sulfate were nebulized directly, or after being reduced in size by extrusion through 1 or 0.4microm polycarbonate membrane filters. MLVs were very unstable to jet nebulization and stability was not markedly enhanced when vesicles were extruded before nebulization, such that drug losses from delivered liposomes using the Pari nebulizer were up to 88% (i.e. only 12% retained in liposomes). The Aeroneb Pro-8microm nebulizer was less disruptive to liposomes, completed nebulization in a much shorter time, and produced greater mass output rate than the Pari nebulizer. However, aerosol droplets were larger, total drug and mass outputs were lower and aerosolization performance was dependent on formulation. Vibrating-mesh nebulization was less disruptive to liposomes extruded through the 1microm membranes compared with the non-extruded MLVs, so that the retained entrapment of the drug in the nebulized vesicles was 56% and 37%, respectively. However, extrusion of liposomes to 0.4microm resulted in reduced stability of liposomes to vibrating-mesh nebulization (retained entrapment=41%) which was attributed to the reduced liposome lamellarity and subsequent reduced resistance to nebulization-induced shearing. This study has shown that vibrating-mesh nebulization using the customized large aperture mesh nebulizer (Aeroneb Pro-8microm) had a less disruptive effect on liposomes and produced a higher output rate compared with the Pari LC Plus air-jet nebulizer. On the other hand, the air-jet nebulizer produced higher total mass and drug outputs and smaller aerosol droplets.
机译:使用喷气雾化器(Pari LC Plus)和定制的大孔径振动筛网雾化器(Aeroneb Pro-8microm)评估了脂质体的气溶胶性质及其对雾化的物理稳定性。直接将包埋硫酸沙丁胺醇的大豆磷脂酰胆碱:胆固醇(摩尔比为1:1)多层脂质体(MLV)雾化,或通过1或0.4微米的聚碳酸酯膜滤器挤出以减小尺寸。 MLV对喷射雾化非常不稳定,在雾化之前将囊泡挤出时,稳定性没有显着提高,因此使用Pari雾化器从输送的脂质体中损失的药物高达88%(即仅12%保留在脂质体中)。与Pari雾化器相比,Aeroneb Pro-8microm雾化器对脂质体的破坏较小,可在更短的时间内完成雾化,并产生更高的质量输出率。但是,气雾滴较大,药物和质量的总产量较低,并且气雾化性能取决于制剂。与未挤出的MLV相比,振动筛网雾化对通过1微米膜挤出的脂质体的破坏较小,因此,药物在雾化囊泡中的截留率分别为56%和37%。但是,将脂质体挤出至0.4微米会导致脂质体对振动网状雾化的稳定性降低(保留的截留率= 41%),这归因于脂质体的层状性降低以及随后对雾化诱导的剪切的抗性降低。这项研究表明,与Pari LC Plus空气喷射雾化器相比,使用定制的大口径网状雾化器(Aeroneb Pro-8microm)进行的振动筛雾化对脂质体的破坏作用较小,并产生了更高的输出速率。另一方面,喷气式雾化器产生更高的总质量和药物输出以及更小的气溶胶液滴。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号